Skip to main content
. 2021 Nov 12;11:22195. doi: 10.1038/s41598-021-01690-9

Figure 8.

Figure 8

Inhibition of Spike-pseudotyped VSV(S) penetration into human A549 lung cell by cardiac glycosides. (a) Measurement of inhibition by luminescence background subtract. VSV(S) was pre-treated with drugs for 1 h, and then exposed to cells in DMEM for 2 h. VSV(S) mixture was then replaced by whole medium and incubated for 24 h. Data are the averages of N = 3 independent experiments. Error bars are ± SE. (b) Measurement by luminescence ratio. (c) Measurement by % of positive control. (d) Negative control with mouse 3T3 cells missing hACE2, measured by luminescence background subtract method.